SPINE
A meta analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graft
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2014;2(16):30 PLoS One. 2014 Jun 2;9(6):e97049. doi: 10.1371/journal.pone.0097049. eCollection 2014.19 randomized controlled trials (n=1852) were included in this meta-analysis comparing bone morphogenetic protein (BMP) to autogenous iliac crest bone graft (ICBG) in lumbar fusion for patients with lumbar degenerative disease. Results demonstrated a significantly higher fusion rate, significantly lower reoperation rate, and a significantly shorter operation time favouring BMP over ICBG. Hospital stay was borderline significant in favour of BMP, while clinical success, complication rate, blood loss, patient satisfaction, work status, return to work were not significantly different between patient cohorts.
Were the search methods used to find evidence (original research) on the primary question or questions stated?
Was the search for evidence reasonably comprehensive?
Were the criteria used for deciding which studies to include in the overview reported?
Was the bias in the selection of studies avoided?
Were the criteria used for assessing the validity of the included studies reported?
Was the validity of all of the studies referred to in the text assessed with use of appropriate criteria (either in selecting the studies for inclusion or in analyzing the studies that were cited)?
Were the methods used to combine the findings of the relevant studies (to reach a conclusion) reported?
Were the findings of the relevant studies combined appropriately relative to the primary question that the overview addresses?
Were the conclusions made by the author or authors supported by the data and or analysis reported in the overview?
How would you rate the scientific quality of this evidence?
はい = 1
不確実＝0.5
無関係 = 0
いいえ = 0
報告基準評価では、著者が出版物内で試験の方法論的特徴や試験特性を報告する際の透明性を評価します。評価は以下の5つのカテゴリーに分類されます。
4/4
Introduction
4/4
Accessing Data
4/4
Analysing Data
4/4
Results
3/4
Discussion
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
Fragility Indexは、重要な所見の解釈を助けるツールで、結果の強さの尺度を提供します。Fragility Indexは、その所見が有意でなくなるために、二項対立の結果に追加する必要がある連続した事象の数を表します。数値が小さいほど弱い所見を表し、数値が大きいほど強い所見を表します。
なぜ今この研究が必要なのですか？
In lumbar fusion surgery, autogenous iliac crest bone (ICBG) is primarily used as a graft. Nonetheless, well-documented complications have included morbidity of the donor site and a high incidence of nonunion. In light of this, bone morphogenetic proteins (BMPs) have been developed as an alternative. Large scale production was achieved following advancements in gene sequencing and recombinant techniques. Both rhBMP-2 and rhBMP-7 have been approved by the FDA. This meta-analysis was needed to evaluate the comparative efficacy of BMPs to ICBG in spinal fusion surgery.
主な研究課題は何ですか？
How does the safety and efficacy of bone morphogenetic proteins compare to autogenous iliac crest bone grafts in lumbar fusion surgery?
重要な知見は？
- Fusion rate was reported in 17 studies (BMP: n=610, ICBG: n=523). Pooled analysis indicated a significant difference, in favour of BMP over ICBG, although with moderate heterogeneity (RR: 1.13 [95% CI 1.05-1.23]; p=0.003; I^2=52%). Subgroup analysis of BMP-2 only demonstrated similar results (RR: 1.16 [95% CI 1.06–1.27]; P = 0.001; I^2=62%). The BMP-7 subgroup indicated contrasting results (RR: 0.90 [95% CI 0.69-1.17]; p=0.43; I^2=0%).
- Clinical success was assessed in 8 studies (BMP: n=431, ICBG: n=265). Pooling of data demonstrated no significant difference between groups (RR: 1.04 [95% CI 0.95-1.13]; p=0.38; I^2=2%).
- Complication rate was pooled from 9 studies (BMP: n=605, ICBG: n=444) and results indicated no significant between group difference (RR: 0.96 [95% CI 0.85-1.09]; p=0.54; I^2=0%).
- Reoperation rate from 14 studies were pooled for analysis (BMP:n=1004, ICBG: n=766). Results demonstrated a significantly lower rate for BMP over ICBG (RR: 0.57 [95% CI 0.42-0.77]; p=0.0002; I^2=0.66).
- Pooled results favoured BMP over ICBG significantly, with respect to operating time (RR: -0.32 [95% CI -0.55 to -0.08]; p=0.009; I^2=79%), and hospital stay (RR: -0.56 [95% CI -1.12 to -0.01]; p=0.05; I^2=70%), whereas comparable results were observed for blood loss (RR: -50.24 [95% CI -117.38 to 16.90]; p=0.14; I^2=77%).
- Patient satisfaction, work status, and return to work were not significantly different between groups (p=0.58, p=0.63, and p=0.68, respectively) when pooled.
最も覚えておくべきことは？
Pooled analyses demonstrated significantly higher fusion rates, lower reoperation rates, and shorter operation times with bone morphogenetic protein (BMP) when compared to autogenous iliac crest bone graft. Additionally, difference in hospital stay was borderline significant in favour of BMP, whereas clinical success, complication rate, blood loss, patient satisfaction, work status, return to work were comparable between groups.
それが私の患者ケアにどのように影響するか？
The results suggest that bone morphogenetic protein increases fusion rate while reducing reoperation rates and operation times for lumbar fusion in patients with systematic lumbar degenerative disease. Clinical success and complication rates, however, were similar to those of the standard autogenous iliac crest bone grafting procedure. Additional high-quality randomized controlled trials are needed to determine the long-term effects of bone morphogenetic protein, and whether it is superior to autogenous iliac crest bone grafting.
免責事項
このページに記載されている内容は、情報提供のみを目的としたものであり、専門的な医療アドバイス、診断、治療の代わりとなるものではありません。治療が必要な場合は、必ず医師の診断を仰ぐか、最寄りの救急外来を受診してください。このページに記載されている内容に関して個人が表明した意見、信念、見解は、OrthoEvidenceの意見、信念、見解を反映するものではありません。
0の4 月間無料記事のロック解除
